We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

ALIFAX DIAG/SRE

Develops automated diagnostic instruments for ESR testing and Bacterial Culture read more Featured Products: More products

Download Mobile App





Alifax Demonstrates Automated Solutions to Improve Performance in Laboratory Settings

By LabMedica International staff writers
Posted on 07 Feb 2024

At Medlab Middle East 2024, Alifax (Polverara, Italy) is showcasing its innovative solutions designed to enhance efficiency, accuracy, and reliability in laboratory settings. More...

Visitors to the Alifax booth can discover firsthand the company’s automated solutions: the new Test1 2.0 ESR system, I-dOne for fast ID, Molecular Mouse RT-PCR & Sepsis panel, fast phenotypic MDRO screening, and more, all engineered to deliver precise results that drive better patient outcomes. The Test1 2.0 ESR system is a new generation instrument from Alifax that is designed for ESR determination in less than 20 seconds. The new and updated Alifax analyzer allows testing of the ESR rate and overcomes the majority of the variables and limitations of the classical sedimentation method, thanks to the capillary photometry technology.

Alifax is also highlighting I-dOne which uses ATR-FTIR technology to identify the bacterial spectra, which can be considered as the molecular fingerprint of microorganisms. I-dOne analyzes the spectrum produced by the interaction between intact microbial cells and IR light through the vibrational state of their chemical bonds. Each species produces a unique fingerprint-like FTIR spectrum. Results are reported as Microorganism ID along with a relative score that represents the reliability of the identification to known vibrational profiles of species present in the reference database.

In addition, Alifax is showcasing the Molecular Mouse RT-PCR & Sepsis panel which provides qualitative and fast analysis of target molecules through real-time PCR and ready-to-use cartridges. The Molecular Mouse system is the world’s first handheld platform for the Real-Time PCR. It uses ready-to-use lab-on-chip cartridges, with all lyophilized reagents in each micro-well, making it possible to perform up to six simultaneous multiplex reactions. Alifax’s Sepsis panel is the largest panel, with 64 different targets, for the rapid detection of microorganisms of major clinical relevance and their antibiotic-resistance genes, starting from positive blood cultures.

Related Links:
Alifax


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Modular Hemostasis Automation Solution
CN Track
New
Automatic Hematology Analyzer
LABAS F9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The discovery of early markers for ovarian cancer that would have improved sensitivity could aid detection (Photo courtesy of Adobe Stock)

Highly Accurate Biomarkers Could Detect Ovarian Cancer Before Clinical Diagnosis

Ovarian cancer is a deadly and challenging disease, primarily because early detection is difficult. Most women (70-75%) are diagnosed only after the cancer has already spread, which significantly reduces... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
MEDLAB 2024
Copyright © 2000-2025 Globetech Media. All rights reserved.